These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17962616

  • 1. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
    Tabernero MD, Espinosa AB, Maillo A, Rebelo O, Vera JF, Sayagues JM, Merino M, Diaz P, Sousa P, Orfao A.
    Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
    [Abstract] [Full Text] [Related]

  • 2. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM, Tabernero MD, Maíllo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de Alava E, Garcia-Macias MC, Orfao A.
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [Abstract] [Full Text] [Related]

  • 3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Gonçalves JM, Santos-Briz A, Morales F, Orfao A.
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [Abstract] [Full Text] [Related]

  • 4. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A, Orfao A, Espinosa AB, Sayagués JM, Merino M, Sousa P, Lara M, Tabernero MD.
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [Abstract] [Full Text] [Related]

  • 5. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features.
    Tabernero MD, Espinosa AB, Maíllo A, Sayagués JM, Alguero Mdel C, Lumbreras E, Díaz P, Gonçalves JM, Onzain I, Merino M, Morales F, Orfao A.
    Am J Clin Pathol; 2005 May; 123(5):744-51. PubMed ID: 15981814
    [Abstract] [Full Text] [Related]

  • 6. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.
    Sayagués JM, Tabernero MD, Maillo A, Díaz P, Rasillo A, Bortoluci A, Gomez-Moreta J, Santos-Briz A, Morales F, Orfao A.
    Cytometry; 2002 Jun 15; 50(3):153-9. PubMed ID: 12116338
    [Abstract] [Full Text] [Related]

  • 7. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB, Mackintosh C, Maíllo A, Gutierrez L, Sousa P, Merino M, Ortiz J, de Alava E, Orfao A, Tabernero MD.
    Eur J Hum Genet; 2008 Dec 15; 16(12):1450-8. PubMed ID: 18628790
    [Abstract] [Full Text] [Related]

  • 8. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.
    Maillo A, Orfao A, Sayagues JM, Diaz P, Gómez-Moreta JA, Caballero M, Santamarta D, Santos-Briz A, Morales F, Tabernero MD.
    J Clin Oncol; 2003 Sep 01; 21(17):3285-95. PubMed ID: 12947064
    [Abstract] [Full Text] [Related]

  • 9. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [Abstract] [Full Text] [Related]

  • 10. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D, Jankowski M, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4443-51. PubMed ID: 14555517
    [Abstract] [Full Text] [Related]

  • 11. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
    Espinosa AB, Tabernero MD, Maíllo A, Sayagués JM, Ciudad J, Merino M, Alguero MC, Lubombo AM, Sousa P, Santos-Briz A, Orfao A.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):772-80. PubMed ID: 16467088
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.
    Cancer; 2003 Feb 01; 97(3):601-9. PubMed ID: 12548602
    [Abstract] [Full Text] [Related]

  • 13. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel H.
    Clin Cancer Res; 1999 Nov 01; 5(11):3569-77. PubMed ID: 10589773
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D, Brunon J, Avet-Loiseau H, Campone M, Mosnier JF.
    Hum Pathol; 2006 Apr 01; 37(4):415-21. PubMed ID: 16564915
    [Abstract] [Full Text] [Related]

  • 15. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features.
    Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK.
    Acta Neuropathol; 2008 Sep 01; 116(3):289-301. PubMed ID: 18604545
    [Abstract] [Full Text] [Related]

  • 16. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S, Hashimoto N, Fushiki S, Date K, Mori T, Fujimoto M, Nakagawa Y, Ueda S, Abe T, Inazawa J.
    Cancer; 1998 Jul 15; 83(2):360-6. PubMed ID: 9669820
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ, Sung CO, Kang SY, Do IG, Suh YL.
    Hum Pathol; 2013 Feb 15; 44(2):260-8. PubMed ID: 22995327
    [Abstract] [Full Text] [Related]

  • 18. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays.
    Tabernero MD, Maíllo A, Nieto AB, Diez-Tascón C, Lara M, Sousa P, Otero A, Castrillo A, Patino-Alonso Mdel C, Espinosa A, Mackintosh C, de Alava E, Orfao A.
    Genes Chromosomes Cancer; 2012 Jun 15; 51(6):606-17. PubMed ID: 22371336
    [Abstract] [Full Text] [Related]

  • 19. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C, Liprandi A, Colin C, Giorgi R, Quilichini B, Metellus P, Figarella-Branger D.
    Am J Clin Pathol; 2005 Aug 15; 124(2):252-8. PubMed ID: 16040297
    [Abstract] [Full Text] [Related]

  • 20. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S, San Miguel T, Gil-Benso R, Muñoz-Hidalgo L, Roldan P, Gonzalez-Darder J, Cerda-Nicolas M, Lopez-Gines C.
    Clin Neuropathol; 2013 Aug 15; 32(4):311-7. PubMed ID: 23442303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.